Lithium neurotoxicity at low therapeutic doses hypotheses for causes and mechanism of action following a retrospective analysis of published case reports

Acta Neurologica Belgica

Volumn 96, Issue 4, 1996, Pages 281-293

  Emilien, Gérard ^a,b   Maloteaux, Jean Marie ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b Wyeth Ayerst Research European CR and D Department   (France)

Author keywords

Lithium; Manic depressive illness; Neuroleptics; Neurotoxicity

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CARBAMAZEPINE; LITHIUM; NEUROLEPTIC AGENT;

ADULT; AGED; CASE REPORT; DRUG BLOOD LEVEL; FEMALE; HUMAN; HYPOTHESIS; MALE; NEUROTOXICITY; REVIEW;

EID: 0030463698     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. ADDY R. O., FOLIART R. H., SARAN A. S., SCHUBERT D. S. P. EEG observations during combined haloperidol- Lithium treatment. Biol. Psychiatry, 1986, 21 : 170-176.
2. ADITYANJEE. Lithium maintenance. Lancet, 1987, 1 : 866-867.
3. ADITYANJEE. The syndrome of irreversible lithium effectuated neurotoxicity. J. Neurol. Neurosurg. Psychiatry, 1987, 50 : 1246.
4. ADITYANJEE. The Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (SILENT). Pharmacopsychiat., 1989, 22 : 81-83.
5. AHLENIUS S., ENGEL J. Potentiation by lithium of the haloperidol-induced behavioural suppression. J. of Neural. Transm., 1974, 35 : 83-86.
6. AKISKAL H. S. "Grayscaling" the affective disorders : Part 11 : Clinical issues pertaining to soft bipolar disorders and temperament. Currents In Affective Illness, 1994, 13 : 5-15.
7. AMDISEN A. Serum level monitoring and clinical pharmacokinetics of lithium. Clinical Pharmacokinetics, 1977, 2 : 73-92.
8. American Psychiatric Association. Practice guidelines for the treatment of patients with bipolar disorder. Am. J. Psychiatry, 1994, 151 (4 Suppl.) : 1-36.
9. ANDREOLI V. M. A sex difference in some toxic effects of lithium carbonate. Experientia, 1968, 24 : 1155.
10. AUSTIN L. S., ARANA G. W., MELVIN J. A. Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients. J. Clin. Psychiatry, 1990, 51 : 8, 344-345.
11. AVISSAR S., SCHREIBER G., DANSON A., BELMAKER R. H. Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature (London), 1988, 331 : 440-442.
12. BAILINE S. H., DOFT M. Neurotoxicity induced by combined lithium-Thioridazine treatment. Biol. Psychiatry, 1986, 21 : 834-837.
13. BAPTISTA T., TENEUD L., CONTRERAS, ALASTRE T., BURGUERA J. L., DE BURGUERA M., DE BAPTISTA E., WEISS S., HERNANDEZ L. Lithium and body weight gain. Pharmacopsychiat., 1995, 28 : 35-44.
14. BAPTISTA T., MURZI E., BURGUERA J. L., BURGUERA M., HERNANDEZ L. Mechanism of the sex-dependent effect of lithium on body weight in rats. Pharmacol. Biochem. Behav., 1991, 38 : 533-537.
15. BELL A. J., COLE A., ECCLESTON D., FERRIER I. N. Lithium neurotoxicity at normal therapeutic levels. Br. J. Psychiatry, 1993, 162 : 689-692.
16. BEKKER F. M. Lithium bij bejaarden. In : NOLAN W. A., REMPAR G. M. Juan, VAN GENT E. M. (eds.) : "Lithium : de stand van zaken" Utrech, Elinkwijm 1st ed., 1987, 76-79.
17. BERRIDGE M. J., DOWNESS C. P., HANLEY M. R. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem. J., 1982, 206 : 587-595.
18. BOND P. A., BROOKS B. A., JUDD A. The distribution of lithium, sodium and magnesium in rat brain and plasma after various periods of administration of lithium in the diet. Brit. J. Pharmacol., 1975, 53 : 235-239.
19. BOWDEN C. L. Treatment of bipolar disorder. In : SCHATZBERG A. F., NEMEROFF C. B., editors. The American Psychiatric Press textbook of Psychiatry. Washington DC : American Psychiatric Press, 1995.
20. BROUWERS J. R. B., DE SMET P. A. Pharmacokinetic - pharmacodynamic drug interactions with non-steroidal anti-inflammatory drugs. Clin. Pharmacokinet., 1994, 27 : 462-485.
21. COFFEY C. E., ROSS D. R. Treatment of Lithium/ Neuroleptic Neurotoxicity during lithium maintenance. Am. J. Psychiatry, 1980, 137 : 736-737.
22. COHEN W. J., COHEN N. H. Lithium carbonate, haloperidol, and irreversible brain damage. JAMA, 1974, 230 : 1283-1286.
23. Cytel software corporation (1989, 1991) StatXact. Statistical Software for Exact Nonparametric Inference. User Manual version 2.
24. EISENSTADTER A., SEISER A., BRAININ M. Neurotoxicity in long-term lithium therapy : an electroneurographic study. Wien-Wochenschr., 1989, 101 (5) : 166-168.
25. ENGEL J., BERGEN U. Effects of lithium on behavior and central monoamines. Acta Psychiatr. Scand. 1980, 61 (suppl. 280) : 133-142.
26. FAICH G. A. National adverse drug reaction reporting. 1984-1989. Arch. Intern. Med. 1991, 151 : 1645-1647.
27. FERRON G., DEBRAY M., BUNEAUX F., BAUD F. J., SCHERMAN J. M. Pharmacokinetics of lithium in plasma and red blood cells in acute and chronic intoxicated patients. Int. J. of Clin. Pharmacol. Ther., 1995, 33 (6) : 351-355.
28. FRAZER A., MENDELS J., SECUNDA S., COCHRANZ C. M., BINI C. M. The prediction of brain lithium concentrations from plasma or erythrocyte measure. J. Psychiatr. Res., 1973, 10 : 1-7.
29. FRIEDMAN B. C., BEKES C. E., SCOTT W. E., BARTTER Th. ARDS following acute lithium carbonate intoxication. Intensive Care Med., 1992, 18 : 123-124.
30. FULLER A. M., SAJATOVIC M. Neurotoxicity resulting from a combination of lithium and loxapine. J. Clin. Psychiatry, 1989, 50 (5) : 187.
31. GAY C., OLIE J. P., DAGHER G., COMBES A., BINET P., LOO H., DENIKER P. Etude de cinétique du rapport érythroplasmatique du lithium. Thérapie, 1984, 39 : 139-145.
32. HAMBRECHT M. Lithium and pseudohallucinations : A rare side effect. Biol. Psychiatry, 1995, 37 : 120-121.
33. HAY G., SIMPSON N. Neurotoxicity associated with therapeutic serum lithium levels. Lancet, 1982, July 17, 160-161.
34. HONIG P. K., CANTILENA L. R. Polypharmacy : pharmacokinetic prespectives. Clin. Pharmacokinet., 1994, 26 : 85-90.
35. HOPF G., MATHIS B. Adverse reactions reporting and age. Lancet, 1988, 2 : 1079-1080.
36. HUNTER R. Steady - state pharmacokinetics of lithium carbonate in healthy subjects. Br. J. Clin Pharmacol., 1988, 25 : 375-380.
37. JENSEN H. V., PLENGE P., MELLERUP E. T., DAVIDSEN K., TOFTEGAARD L., AGGERNAES H., BJORUM N. Lithium prophylaxis of manic-depressive disorder : daily lithium dosing schedule versus every second day. Acta Psychiatr. Scand., 1995, 92 : 69-74.
38. JOHNSON G., GERSHON S., HEKIMIAN L. J. Controlled evaluation of lithium and chlorpromazine in the treatment of manic states. Comp. Psychiat., 1968, 9: 563-573.
39. KAMIANA S. H. Lithium-induced paranoid hallucinatory state. Br. J. Psychiatry, 1991, 154 : 273.
40. KEMPERMAN C. J. F., GERDES J. H., DE ROOIJ J., VENCKEN L. M. Reversible lithium neurotoxicity at normal serum level may refer to intracranial pathology. Journal of Neurology, Neurosurgery and Psychiatry, 1989, 52 : 678-692.
41. KLEIN D. F., GITTELMAN R., QUITKIN F. Diagnosis and drug treatment of psychiatric disorders : adults and children, 2nd ed. Williams & Wilkins, Baltimore, Maryland, 1981.
42. KLEIN L., KLEIN M., STURM H. et al. The frequency of adverse drug reactions as dependent upon age, sex, and duration of hospitalization. Int. J. Clin. Pharmacol., 1976, 13 : 187-195.
43. LOUDON J. B., WARING H. Toxic reactions to lithium and haloperidol. Lancet, 1976, 11 : 1088.
44. MARCHAND M. P. Lithium et fonctions cérébrales. Encephale, 1985, 11 : 235-246.
45. MCGOVERN A. J., MAKANJUOLA R., ARBUTHNOTT G. W., LOUDON J. B., GLEN A. I. M. Lithium Neurotoxicity. I. The concentration of lithium in dopaminergic systems of rat brain determined by flameless atomic absorption spectrophotometry. Acta Pharmacol. et Toxicol., 1978, 42 : 259-263.
46. MOORE A. P., MACFARLANE I. A, BLUMHARDT L. D. Polyneuropathy in lithium intoxication. Muscle & Nerve, 1991, 14 : 578.
47. NAHORSKI S. R., RAGAN C. I., CHALLISS R. A. J. Lithium and the phosphoinositide cycle : an example of uncompetitive inhibition and its pharmacological consequences. Trends Pharmacol. Sci., 1991, 12 : 297-303.
48. NEWMAN M. E., BELMAKER R. H. Effects of lithium in vitro and in vivo on components on components of the adenylate cyclase from rat brain. Neuropharmacology, 1987, 26 : 211-217.
49. PANDEY G. N., GOEL I., DAVIS M. Effect of neuroleptic drugs on lithium uptake by the human erythrocyte. Clin. Pharmacol. Ther., 1979, 26 (1) : 96-102.
50. PELLETIER J., HABIB M., PELLISSIER J. F., CREVAT A., KHALIL R. Séquelles neurologiques de l'association neuroleptiques-lithium : rôle de l'hyperthermie. La Revue de Médecine Interne, 1991, XII (3): 187-191.
51. PRAKASH R., KELWALA S., BAN T. A. Neurotoxicity in patients with schizophrenia during lithium therapy. Comprehensive Psychiatry, 1982, 23 (3) : 271-273.
52. PRETTYMAN R. Lithium neurotoxicity at therapeutic serum levels. Brit. J. psychiatry, 1994, 164 : 123.
53. PRICE W. A., ZIMMER B. Lithium-induced akathisia. J. Clin. Psychiatry, 1987, 48 : 2.
54. PRICE W. A., GIANNINI J. Neurotoxicity caused by lithium-verapamil synergisin. J. Clin. Pharmacol., 1986, 26 : 717-719.
55. RAGHEB M. The clinical significance of lithium/ nonsteroidal antlinflammatory drug interaction in children with arthritis. J. Rheumatol., 1990, 17 (11) : 1469-1494.
56. RICHELSON E., GORKIN R. A. Lithium ion entry into cultured cells of neural origin. In : OBIOLS J., BALLUR C., MANELUR F., GONZALES, PUJOL J. eds. Biological Psychiatry Today. Amsterdam, Elsevier/North Holland Biomedical Press, 1979, 1161-1166.
57. RITTMANNSBERGER H., LEBLHUBER F. Asterixis induced by Carbamazepine, Biol. Psychiatry, 1992, 32 : 364-364.
58. SAMSONE M. E., ZIEGLER D. K. Brain and nervous system. In : JOHNSON F. N. ed. Depression & mania : modern lithium therapy. Oxford : IRL Press, 1987.
59. SHALEV A., MUNITZ H. The neuroleptic malignant syndrome : agent and host interaction. Acta Psychiatrica Scandinavica, 1986, 73 : 337-347.
60. SHERMAN W. R. Lithium and the phosphoinositide signalling system. In : Lithium and the cell. N. J. BIRCH, (ed.). Academic Press, New York, 1991, 121-157.
61. SHOPSIN B., KIM S. S., GERSHON S. A controlled study of lithium vs chlorpromazine in acute shizophrenic. Br. J. Psychiatr., 1971, 119 : 435-450.
62. SHUKLA S., GOODWIN C., LONG L. E. B., MILLER M. G. Lithium-Carbamazepine neurotoxicity and risk factors. Am. J. Psychiatry, 1984, 141 : 1604-1606.
63. SIEGEL S., CASTELLAN N. J. Nonpararnetric Statistics for the behavioral sciences, 2nd edition. McGraw-Hill Book Company, New York.
64. SLONIM R., MCLARTY B. Sixth cranial nerve palsy - Unusual presenting symptom of lithium toxicity ? Can. J. Psychiatry, 1985, 30 : 443-444.
65. SMALL J. G., KLAPPER M. H., MARHENKE J. D., MILSTEIN V., WOODHAM G. C., KELLAMS J. Lithium combined with carbamazepine or haloperidol in the treatment of mania. Psychopharmacology Bulletin, 1995, 31 (2) : 265-272.
66. SPRING G. K. Neurotoxicity with combined use of lithium and thioridazine. J. Clin. Psychiatry, 1979, 40 : 135-138.
67. VALECHA N., TAYAL G., TRIPATHI K. D. Single dose pharmacokinetics of lithium and prediction of maintenance dose in manic depressive patients. Ind. J. Med. Res., 1990, 92 : 409-416.
68. VANHOOREN G., DEHAENE I., VAN ZANDYCKE M., PIESSENS F., VANDENBERGH V., VAN HEES J., LAMMENS M., CARTON H. Polyneuropathy in lithium intoxication. Muscle & Nerve, 1990, 13 : 204-208.
69. VANHOOREN G., DEHAENE I., VAN ZANDYCKE M., PIESSENS F., VANDENBERGH V., VAN HEES J., LAMMENS M., CARTON H. Polyneuropathy in lithium intoxication : A reply. Muscle & Nerve, 1991, 14 : 578.
70. VAN DER VELDE C. S. Toxicity of lithium carbonate in elderly patients. Am. J. Psychiat., 1970, 127 : 1075-1077.
71. VERDOUX H., BOURGEOIS M. L. A case of lithium neurotoxicity with irreversible cerebellar syndrome. The Journal of Nervous and Mental Disease, 1990, 178 (12) : 761-762.
72. VESTERGAARD P. I., POULSTRUP I., SCHOU M. Prospective studies on a lithium cohort 3 : tremor, weight gain, diarrhea, psychological complaints. Acta Psychiatr. Scand., 1988, 78 : 434-441.
73. WEST A. P., MELTZER H. Y. Paradoxical lithium neurotoxicity : A report of five cases and a hypothesis about risk for neurotoxicity. Am. J. Psychiatry, 1979, 136 (7) : 963-966.
74. WEST A. P. Lithium neurotoxicity in schizophrenic and schizoaffective patients. Behavioral staterelated aspects of neurotoxicity. Int. Pharmacopsychiatry, 1982, 17 : 91-103.
75. WRIGHT B. A., JARRETT D. B. Lithium and Calcium Channel Blockers : Possible Neurotoxicity. Biol. Psychiatry, 1991, 30 : 635-636.
76. YASSA R. A case of lithium-Chlorpromazine interaction. J. Clin. Psychiatry, 1986, 47 : 90-91.